Get on track with future-proof solutions
Daily operations in pharmaceutical manufacturing are demanding, so facilities rarely maintain an overview of pharmaceutical trends and technologies. When manufacturing sites have to introduce new products and technologies, local experience is often insufficient. The risk is cost overrun, delayed production and postponed product launches. When your site needs the expertise to select and implement new technology or knowledge, NNE Pharmaplan can help you to future-proof solutions and assist you with our broad overview on new best practice technologies and solutions. We are experienced in technology assessment, selection and implementation, and are used to working with preferred suppliers.
SPECIALITY DRUGS AND TREATMENTS
Drug products have become more complex and specialised, and this trend will continue. Small production volumes for orphan drugs and other treatments for rare diseases are part of the future agenda. Ultimately, personalised drugs and treatments in very small volumes will be hitting the market. These new treatments, diagnostics and combinational medicines are bringing new manufacturing challenges, which require both flexible and robust solutions. NNE Pharmaplan can help you with these future-proof solutions and has already been involved in projects concerning new facilities for advanced therapies and smaller batches.
The demand for flexibility in biopharmaceutical has increased over the last 10 years. Combined with the right knowledge, flexible single-use equipment is a good solution to the pharma world’s rapid process and technology development.
The advantages are clear: lower investments, increased flexibility, faster scalability and tech transfer, and lower contamination risk. With our project experience and strong supplier relations within single-use technology we can help you find the balance between single-use and stainless steel solutions based on best practice experience.
One of the new topics in focus in pharmaceutical manufacturing is continuous manufacturing, but very few pharma companies have tried it on a commercial scale. This type of manufacturing, however, clearly shows a level of manufacturing flexibility that no other technology can provide. There have been regulatory challenges to the adoption of continuous manufacturing, but also some very successful implementations, which have been approved.
NNE Pharmaplan has already worked with this technology and can help you implement it. Our technology experts have in-depth knowledge including the know-how to leverage the opportunities the technology offers.
WHY PARTNER WITH NNE PHARMAPLAN?
- We assist in selecting and implementing new technology on a global scale
- We are directly involved in defining and evaluating new standards
- We have specialists who are globally recognised in their field